种植体疾病风险评估工具(IDRA)在牙周炎治疗史患者中的评价
本回顾性研究在至少5年功能的种植固定修复牙周炎治疗患者中评估IDRA工具预测种植体周围炎的能力。79例患者中,IDRA中危42.5%、高危56.3%,高危者发生种植体周围炎的比值比为2.727(95%CI:0.793-9.376),AUC为0.613(95%CI:0.464-0.762)。IDRA算法可能有助于评估中高危患者。
要点
- IDRA将56.3%患者归为高危,42.5%归为中危。
- 高危者种植体周围炎发生比值比为2.727,但无统计学显著性。
- IDRA预测种植体周围炎的AUC为0.613,区分能力有限。
核心结论
- 在回顾性研究局限性内,IDRA算法可能有助于评估中高危种植体周围炎风险患者。
研究设计与样本
- 回顾性研究,从接受定期牙周支持治疗至少5年的种植患者库中筛选239例,最终79例符合纳入标准并接受IDRA评估。
主要发现
- 79例患者平均年龄59.0岁(范围40-79岁),男性43例、女性36例,吸烟者8例。
- IDRA风险分布:中危34例(42.5%),高危45例(56.3%),低危1例被排除。
- 中危组种植体周围炎4例(12%),高危组12例(27%)。
- 高危相比中危发生种植体周围炎的比值比为2.727(95%CI:0.793-9.376),组间无统计学显著差异。
- IDRA风险与最近随访时种植体周围炎患病率关联的AUC为0.613(95%CI:0.464-0.762)。
临床怎么用
- IDRA可用于牙周炎治疗史种植固定修复患者的中高危风险分层,但预测准确性有限,需结合临床判断。
局限性
- 回顾性研究设计;样本量有限(79例);低危患者仅1例被排除,无法充分评估低危组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate the Implant Disease Risk Assessment (IDRA) tool for the prediction of peri-implantitis in treated periodontitis patients with implant-supported fixed dental prostheses (FDPs) after at least 5 years of function. MATERIAL AND METHODS: From the patient pool of implant patients enrolled in a regular supportive periodontal therapy programme (SPT) for at least 5 years, 239 patients were screened. Eighty patients met the inclusion criteria and underwent evaluation through the criteria of the IDRA tool. Areas under the curve (AUCs) for receiver operating characteristic (ROC) curves including 95% confidence intervals were estimated. RESULTS: Seventy-nine patients (43 males and 36 females, 8 smokers), aged on average 59.0 years (range: 40-79 years) at baseline (i.e. FDP delivery) were analysed. The calculated IDRA-risk was in 34 patients (42.5%) a moderate risk, while 45 patients (56.3%) were considered at high IDRA-risk. One patient categorized at low IDRA-risk was excluded from the analysis. The AUC was 0.613 (95% CI: 0.464-0.762) if the IDRA-risk was associated with prevalence of peri-implantitis at the most recent follow-up. Peri-implantitis was diagnosed in 4 patients (12%) at moderate and in 12 patients (27%) at high IDRA-risk, respectively. The calculated odds ratio for developing peri-implantitis in patients with high IDRA-risk compared with patients with moderate IDRA-risk was 2.727 with no statistically significant difference between the two groups (95% CI: 0.793-9.376). CONCLUSION: Within the limitations of the present retrospective study, the IDRA algorithm might represent a promising tool to assess patients at moderate or high risk of developing peri-implantitis.
引用
- De Ry SP, Roccuzzo A, Lang NP, et al. Evaluation of the implant disease risk assessment (IDRA) tool: A retrospective study in patients with treated periodontitis and implant-supported fixed dental prostheses (FDPs). Clin Oral Implants Res. 2021. PMID: 34388276. doi:10.1111/clr.13828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。